A Science and Technology Blog
“Considering the emergency and unmet medical need in Covid-19, the SEC on December 27 recommended for grant of permission to manufacture and market the Molnupiravir for restricted use under emergency…
Unlike in the case of remdesivir, both the drugs — Pfizer’s paxlovid and Merck’s molnupiravir — are oral pills and so can be administered outside hospital settings. These drugs are…
In an email, Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore explains the significance of paxlovid antiviral for treatment, its mode of action, and the need for a combination…
Preliminary data, which is yet to be peer-reviewed, shows molnupiravir can reduce risk of hospitalisation or death by 50% in non-hospitalised adult patients with mild-to-moderate COVID-19 disease. The trial included…
Science Chronicle 